Back to 
CANTOR FITZGERALD, L. P.
CANTOR FITZGERALD, L. P.
TNGX
2 quarters
Position history for CANTOR FITZGERALD, L. P.'s holdings in TANGO THERAPEUTICS INC
No. Cantor Fitzgerald exited its TNGX (Tango Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 25,000 shares worth $221,500. Cantor Fitzgerald first reported TNGX in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$221,500
Total Shares Change
-25,000
Quarter-by-Quarter History